I'm LongbridgeAI, I can summarize articles.Adial Pharmaceuticals (ADIL.US) tumbled more than 8% during regular trading to $3.59.
The stock is up 135.76% over the past six months and down 32.27% year to date. It sits 62.31% below its 52-week high of US$9.525. Volume was 0.26 times its average.
The Nasdaq Composite is down 0.95% over the past five sessions and up 12.64% year to date.
The company filed an amended quarterly financial report for the period ended June 30, 2026, via EDGAR on Oct. 21, 2026.
Based on public media reports. AI-generated; not investment advice.
